Ultragenyx Pharmaceutical Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 3 51 104 271 351 363 434 560
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% inf% 1863.9% 1871.5% 101.4% 161.3% 29.7% 3.4% 19.5% 29.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 100.0% 97.8% 91.3% 97.7% 95.4% 92.2% 89.6% 86.3%
EBIT (mln) -7 -16 -32 -57 -148 -248 -329 -371 -424 -330 -382 -649 -569 -536
EBIT Δ r/r 0.0% 143.6% 101.9% 75.9% 160.2% 67.9% 32.6% 12.9% 14.2% -22.2% 15.6% 70.0% -12.3% -5.8%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% -186471.4% -12593.5% -721.2% -409.0% -121.8% -108.6% -178.6% -131.1% -95.7%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 1 33 29 43 66 63
EBITDA (mln) -7 -16 -35 -57 -146 -248 -329 -542 -412 -322 -381 -639 -517 -469
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% -186471.4% -12593.5% -1051.9% -397.0% -119.0% -108.6% -176.0% -119.0% -83.7%
Podatek (mln) 0 -0 -3 -1 -2 0 -16 1 3 1 1 6 -2 2
Zysk Netto (mln) -7 -16 -35 -60 -146 -246 -302 -198 -403 -187 -454 -707 -607 -569
Zysk netto Δ r/r 0.0% 138.5% 114.7% 70.5% 143.5% 68.8% 22.9% -34.6% 103.8% -53.7% 143.4% 55.8% -14.2% -6.2%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% -184867.7% -11567.3% -383.7% -388.3% -68.8% -129.2% -194.7% -139.7% -101.6%
EPS -0.3 -0.71 -1.21 -2.08 -3.96 -6.21 -7.12 -3.97 -7.12 -3.07 -6.7 -10.12 -8.25 -6.29
EPS (rozwodnione) -0.3 -0.71 -1.21 -2.08 -3.96 -6.21 -7.12 -3.97 -7.12 -3.07 -6.7 -10.12 -8.25 -6.29
Ilośc akcji (mln) 23 23 29 29 37 40 42 50 57 61 68 70 74 91
Ważona ilośc akcji (mln) 23 23 29 29 37 40 42 50 57 61 68 70 74 91
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD